Gefitinib induces apoptosis in human glioma cells by targeting Bad phosphorylation (Q39509236)

12 September 2017

title

Gefitinib induces apoptosis in human glioma cells by targeting Bad phosphorylation (English)

1 reference

12 September 2017

1 reference

Cheng-Yi Chang

1

1 reference

12 September 2017

Chiung-Chyi Shen

series ordinal

2

1 reference

12 September 2017

Hong-Lin Su

series ordinal

3

1 reference

12 September 2017

Chun-Jung Chen

series ordinal

4

1 reference

12 September 2017

publication date

9 July 2011

1 reference

Journal of Neuro-Oncology

12 September 2017

language of work

1 reference

12 September 2017

volume

105

1 reference

12 September 2017

issue

3

1 reference

12 September 2017

page(s)

507-522

1 reference

Genetics of glioblastoma multiforme: mitogenic signaling and cell cycle pathways converge.

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0632-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0632-3

Spotlight on gefitinib in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0632-3

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0632-3

Mutations of the epidermal growth factor receptor in non-small cell lung cancer -- search and destroy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0632-3

A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0632-3

Structural alterations of the epidermal growth factor receptor gene in human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0632-3

Cooperative inhibitory effect of ZD1839 (Iressa) in combination with 17-AAG on glioma cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0632-3

Phase II trial of gefitinib in recurrent glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0632-3

Down-regulation of Bcl-2 and Bcl-xL expression with bispecific antisense treatment in glioblastoma cell lines induce cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0632-3

The expression of a new variant of the pro-apoptotic molecule Bax, Baxpsi, is correlated with an increased survival of glioblastoma multiforme patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0632-3

Amphiregulin promotes BAX inhibition and resistance to gefitinib in non-small-cell lung cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0632-3

The BCL-2 protein family: opposing activities that mediate cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0632-3

Japanese encephalitis virus infection stimulates Src tyrosine kinase in neuron/glia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0632-3

Mitochondrial membrane permeabilization in cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0632-3

Cyclosporine A prevents apoptosis-related mitochondrial dysfunction after neonatal cardioplegic arrest.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0632-3

Molecular mechanisms of ZD1839-induced G1-cell cycle arrest and apoptosis in human lung adenocarcinoma A549 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0632-3

An epidermal growth factor inhibitor, Gefitinib, induces apoptosis through a p53-dependent upregulation of pro-apoptotic molecules and downregulation of anti-apoptotic molecules in human lung adenocarcinoma A549 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0632-3

Iressa induces cytostasis and augments Fas-mediated apoptosis in acinic cell adenocarcinoma overexpressing HER2/neu

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0632-3

p53 enhances gefitinib-induced growth inhibition and apoptosis by regulation of Fas in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0632-3

Gefitinib, a selective EGFR tyrosine kinase inhibitor, induces apoptosis through activation of Bax in human gallbladder adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0632-3

Gefitinib-induced killing of NSCLC cell lines expressing mutant EGFR requires BIM and can be enhanced by BH3 mimetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0632-3

PUMA mediates EGFR tyrosine kinase inhibitor-induced apoptosis in head and neck cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0632-3

Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0632-3

Protein phosphatase 2A dephosphorylation of phosphoserine 112 plays the gatekeeper role for BAD-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0632-3

Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0632-3

Rsk1 mediates a MEK-MAP kinase cell survival signal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0632-3

Okadaic acid: a new probe for the study of cellular regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0632-3

Protein phosphatase 2A enhances the proapoptotic function of Bax through dephosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0632-3

Caspase-8-mediated cleavage of Bid and protein phosphatase 2A-mediated activation of Bax are necessary for Verotoxin-1-induced apoptosis in Burkitt's lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0632-3

Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0632-3

Identification of uncommon chromosomal aberrations in the neuroglioma cell line H4 by spectral karyotyping

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0632-3

Combination of all-trans retinoic acid and interferon-gamma suppressed PI3K/Akt survival pathway in glioblastoma T98G cells whereas NF-kappaB survival signaling in glioblastoma U87MG cells for induction of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0632-3

EGFRvIII and c-Met pathway inhibitors synergize against PTEN-null/EGFRvIII+ glioblastoma xenografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0632-3

Induction of apoptosis by an inhibitor of EGFR in neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0632-3

Phase I pharmacokinetic trial of the selective oral epidermal growth factor receptor tyrosine kinase inhibitor gefitinib ('Iressa', ZD1839) in Japanese patients with solid malignant tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0632-3

Lovastatin enhances gefitinib activity in glioblastoma cells irrespective of EGFRvIII and PTEN status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0632-3

Pilot study of the combination of EGFR and mTOR inhibitors in recurrent malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0632-3

EGFR tyrosine kinase inhibition radiosensitizes and induces apoptosis in malignant glioma and childhood ependymoma xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0632-3

Dose scheduling of the dual VEGFR and EGFR tyrosine kinase inhibitor vandetanib (ZD6474, Zactima) in combination with radiotherapy in EGFR-positive and EGFR-null human head and neck tumor xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0632-3

Pathway analysis of glioblastoma tissue after preoperative treatment with the EGFR tyrosine kinase inhibitor gefitinib--a phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0632-3

Effect of epidermal growth factor on glioma cell growth, migration, and invasion in vitro.

21 January 2018

1 reference

12 December 2020

Advances in the molecular genetics of gliomas.

1 reference

12 December 2020

Flavonoids activated caspases for apoptosis in human glioblastoma T98G and U87MG cells but not in human normal astrocytes

1 reference

12 December 2020

Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A

1 reference

12 December 2020

Oral administration of a novel taxane, an antisense oligonucleotide targeting protein kinase A, and the epidermal growth factor receptor inhibitor Iressa causes cooperative antitumor and antiangiogenic activity.

1 reference

12 December 2020

Extracellular Bad fused to toxin transport domains induces apoptosis

1 reference

12 December 2020

BAD: undertaker by night, candyman by day.

1 reference

12 December 2020

In vivo establishment of T98G human glioblastoma

1 reference

12 December 2020

ZD1839 (Iressa): an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy.

1 reference

12 December 2020

10.1007/S11060-011-0632-3

Identifiers

DOI

1 reference

12 September 2017

1 reference